GLP-1 drugs may influence cancer risk by reversing obesity-related metabolic dysfunction and inflammation. Researchers are ...

The American Society for Nutrition and The Obesity Society recently announced a partnership that offers opportunities for discounted pricing and will advance clinical practice.According to a press ...

A new approach to defining obesity could help physicians better determine which patients need more intensive treatment by ...

There are other reasons to pay attention to Viking Therapeutics.

Type 2 diabetes is still more common in older adults, but the pattern in England is changing. Researchers at Imperial College London say more young adults are now being diagnosed, with some of the ...

The agreement involves Indiana-based drug manufacturer Eli Lilly.

A recent study reveals that risk factors for coronary artery diseases, including obesity and high cholesterol, are emerging ...

Nutrition, diet and lifestyle should become core components of clinical practice and undergraduate medical education to ...

Spread the loveImagine a world where a medication that costs over a thousand dollars a month suddenly becomes accessible for a mere fifty bucks. Sounds almost too good to be true, doesn’t it? Well, ...